SynthesisPharmacoEconomics2024

Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review.

Tobias Sydendal Grand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.